Spondyloarthritis (SpA) is the most frequent extraintestinal manifestation in patients with inflammatory bowel diseases (IBD). When IBD and spondyloarthritis coexist, musculoskeletal and intestinal disease features should be considered when planning a therapeutic strategy. Treatment options for IBD and SpA have expanded enormously over the last few years, but randomized controlled trials with specific endpoints focused on SpA are not available in the IBD setting. To address this important clinical topic, the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and the Italian Society of Rheumatology (SIR) jointly planned to draw updated therapeutic recommendations for IBD-associated SpA using a pseudo-Delphi method. This document presents the official recommendations of IG-IBD and SIR on the management of IBD-associated SpA in the form of 34 statements and 4 therapeutic algorithms. It is intended to be a reference guide for gastroenterologists and rheumatologists dealing with IBD-associated SpA.

The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus / Macaluso, F. S.; Caprioli, F.; Benedan, L.; Bezzio, C.; Caporali, R.; Cauli, A.; Chimenti, M. S.; Ciccia, F.; D'Angelo, S.; Fantini, M. C.; Festa, S.; Iannone, F.; Lubrano, E.; Mariani, P.; Papi, C.; Provenzano, G.; Pugliese, D.; Rispo, A.; Saibeni, S.; Salvarani, C.; Variola, A.; Zenga, M.; Armuzzi, A.; Orlando, A.; Gerli, R.. - In: AUTOIMMUNITY REVIEWS. - ISSN 1568-9972. - 23:5(2024), pp. 1-12. [10.1016/j.autrev.2024.103533]

The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus

Salvarani C.;
2024

Abstract

Spondyloarthritis (SpA) is the most frequent extraintestinal manifestation in patients with inflammatory bowel diseases (IBD). When IBD and spondyloarthritis coexist, musculoskeletal and intestinal disease features should be considered when planning a therapeutic strategy. Treatment options for IBD and SpA have expanded enormously over the last few years, but randomized controlled trials with specific endpoints focused on SpA are not available in the IBD setting. To address this important clinical topic, the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and the Italian Society of Rheumatology (SIR) jointly planned to draw updated therapeutic recommendations for IBD-associated SpA using a pseudo-Delphi method. This document presents the official recommendations of IG-IBD and SIR on the management of IBD-associated SpA in the form of 34 statements and 4 therapeutic algorithms. It is intended to be a reference guide for gastroenterologists and rheumatologists dealing with IBD-associated SpA.
2024
23
5
1
12
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus / Macaluso, F. S.; Caprioli, F.; Benedan, L.; Bezzio, C.; Caporali, R.; Cauli, A.; Chimenti, M. S.; Ciccia, F.; D'Angelo, S.; Fantini, M. C.; Festa, S.; Iannone, F.; Lubrano, E.; Mariani, P.; Papi, C.; Provenzano, G.; Pugliese, D.; Rispo, A.; Saibeni, S.; Salvarani, C.; Variola, A.; Zenga, M.; Armuzzi, A.; Orlando, A.; Gerli, R.. - In: AUTOIMMUNITY REVIEWS. - ISSN 1568-9972. - 23:5(2024), pp. 1-12. [10.1016/j.autrev.2024.103533]
Macaluso, F. S.; Caprioli, F.; Benedan, L.; Bezzio, C.; Caporali, R.; Cauli, A.; Chimenti, M. S.; Ciccia, F.; D'Angelo, S.; Fantini, M. C.; Festa, S.;...espandi
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1568997224000247-main.pdf

Open access

Tipologia: VOR - Versione pubblicata dall'editore
Dimensione 1.44 MB
Formato Adobe PDF
1.44 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1365957
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 4
social impact